Why the study?
Does oral tenofovir-containing PrEP prevent HIV infection in high-risk populations?
Does oral tenofovir-containing PrEP prevent HIV infection in high-risk populations?
Oral tenofovir-containing PrEP is safe and effective for preventing HIV in MSM, serodiscordant couples, and PWID, with efficacy strongly dependent on adherence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Stanton et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: